Loading...
Please wait while we fetch the latest data
Please wait while we fetch the latest data
Curis Lifesciences Limited began as “M/s Loreto Pharmaceuticals,” a partnership firm founded in 2010, engaged in marketing and trading pharma products...
₹null - ₹null
TBA
TBA
NSE/BSE
Registrar: TBA
Curis Lifesciences Limited began as “M/s Loreto Pharmaceuticals,” a partnership firm founded in 2010, engaged in marketing and trading pharma products. The company specializes in the manufacturing of tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. The company operates through three key verticals: loan license manufacturing, contract manufacturing, and direct export under its own brands. Its products are supplied domestically and exported to over 35 countries, including Kenya, Yemen, Nigeria, Myanmar, and Vietnam. With an installed capacity of 138 crore tablets and 15.75 crore capsules annually, Curis has served over 100 customers in loan license and contract manufacturing and is expanding its direct export footprint. The company’s WHO-GMP certified manufacturing facility in Sanand, Gujarat, is equipped with quality control labs and modern production units. Its clientele includes well-known pharmaceutical brands like J B Chemicals, Troikaa Pharmaceuticals, Express Pharma, and Venus International.
Open Date
2025-11-07
Close Date
2025-11-11
Basis of Allotment
TBA
Refund Initiation
TBA
Credit to Demat
TBA
Listing Date
2025-11-14
Download our app to get alerts for GMP changes, subscription, and allotment
Download App